Small for gestational age (SGA): Endocrine and metabolic consequences and effects of growth hormone treatment

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue SUPPL. 3, 2004, Pages 463-469

  Hokken Koelega, A C S ^a   De Waal, W J ^a   Sas, T C J ^a   Van Pareren, Y ^a   Arends, N J T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Blood pressure; Glucose tolerance; Insuline sensitivity; Small for gestational age (SGA), growth hormone; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; BONE MATURATION; CARBOHYDRATE METABOLISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN SENSITIVITY; INTELLIGENCE QUOTIENT; LONG TERM CARE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENDOCRINE GLANDS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INJECTIONS; INSULIN; MALE; PATIENT SELECTION; TIME FACTORS;

EID: 3142705851     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Wennergren M, Wennergren G, Vilbergsson G. Obstetric characteristics and neonatal performance in a four-year small for gestational age population. Obstet Gynecol 1988; 72: 615-620.
2. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, De Hartog H, de Muinck Keizer-Schrama SMPF, Drop SL Children born small for gestational age: Do they catch-up? Pediatr Res 1995; 38: 267-271.
3. Albertsson-Wikland K, Karlberg J. Natural catch-up growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Scand 1994; Suppl 399: 64-70.
4. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995; 38: 733-739.
5. WHO. Energy and Protein Requirements. Report of a Joint FAO/WHO/LIND Expert Consultation. Geneva: WHO, Technical Report Series 724, 1985.
6. Arends NJT, Hokken-Koelega ACS. Body composition and daily food intake in children with short stature after intrauterine growth retardation (IUGR). Horm Res 1998; 50: 47.
7. Albertsson-Wikland K. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acta Paediatr Scand 1989; Suppl 349: 35-41.
8. Stanhope R, Ackland F, Hamill G, Clayton J, Jones J, Preece MA. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intra-uterine growth retardation. Acta Paediatr Scand 1989; Suppl 349: 47-52.
9. De Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SMPF, Drop SL. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 1994; 41: 621-630.
10. Boguszewski M, Rosberg S, Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995; 80: 2599-2606.
11. Boguszewski M, Jansson C, Rosberg S, Carlsson LMS, Albertsson-Wikland K. Changes in serum insulin-like growth factor I and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996; 81: 3902-3908.
12. Job JC, Chatelain P, Rochiccioli P, Ponte C, Olivier M, Sagnard L. Growth hormone response to a bolus injection of 1-44 growth hormone-releasing hormone in very short children with intrauterine onset of growth failure. Horm Res 1990; 33: 161-165.
13. Chatelain P, Job JC, Blanchard J, Ducret JP, Olivier M, Sagnard L, Vanderschueren-Lodeveyckx M. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Endocrinol Metab 1994; 78: 1454-1460.
14. Chaussain JL, Colle M, Landier F. Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation. Acta Paediatr Scand 1994; Suppl 399: 74-75.
15. De Zegher F, Maes M, Gargosky SE, Heinrichs C, du Caju MVL, Thiry G, de Schepper J, Craen M, Breysem L, Löfström A, Jö nsson P, Bourguignon J-P, Malvaux P, Rosenfeld RG. High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab 1996; 81: 1887-1892.
16. Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Olivier M, Ponte C, Rochiccioli P, Vanderschueren-Lodeweyckx M, Chatelain P. Follow-up of three years off treatment with growth hormone and of one post-treatment year in children with severe growth retardation of intrauterine onset. Pediatr Res 1996; 39: 354-359.
17. Boguszewski M, Albertsson-Wikland K, Aronsen S. Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial. Acta Paediatr 1998; 87: 257-263.
18. De Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Lötström A, Butenandt O, Chaussain JL. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies. Acta Paediatr 1996; Suppl 417: 27-31.
19. De Zegher F, Butenandt O, Chatelain PG, Albertsson Wikland K, Jonsson B, Löfstrom A, Chaussain JL. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years. Acta Paediatr 1997: Suppl 423: 207-212.
20. Fjellestad-Paulsen A, Czernichow P, Brauner R, Bost M, Colle M, Lebouc JY, Lecornu M, Leheup B, Limal JM, Raux MC, Toublanc JE, Rappaport R. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr Scand 1998; 87: 511-517.
21. Sas TCJ, Mulder P, Houdijk EC, Jansen M, Reeser HM, Hokken-Koelega ACS. Growth hormone treatment in children with short stature born sinall for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 1999; 84: 3064-3070.
22. Tanner JM, Lejarriaga H, Cameron N. The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases. Pediatr Res 1975; 9: 611-623.
23. Job JC, Rolland A. Histoire naturelle des retards de croissance a debut intra-uterin. Arch Fr Pédiatr 1986; 43: 301-306.
24. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Final height after long-term, continuous GH treatment in short children born small for gestational age (SGA): results of a randomised, double-blind, dose-response GH trial. J Clin Endocrinol Metab 2003; 88: 3584-3590.
25. De Zegher F, Francois I, Van Helvoirt M, Beckers D, Ibáñez L, Chatelain P. Growth hormone treatment of short children born small for gestational age. Trends Endocrinol Metab 1998; 9: 233-237.
26. Sas TCJ, Mulder P, Hokken-Koelega ACS. Body proportions during six years of growth hormone treatment in children with short stature born small for gestational age participating in a randomized, double-blind, dose-response trial. Clin Endocrinol 2000; 53: 675-681.
27. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82: 402-406.
28. Sas TCJ, Mulder P, Hokken-Koelega ACS. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol 2001; 54: 243-251.
29. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega ACS. Effect of discontinuation of GH treatment on risk factors for cardiovascular disease in adolescents born small for gestational age. J Clin Endocrinol Metab 2003; 88: 347-353.
30. Barker DJP, Hales CN, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
31. Sas TCJ, Mulder P, Hokken-Koelega. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab 2000; 85: 3786-3792.
32. Leger J, Carel C, Legand I, Paulsen A, Hassan M, Czernichow P. Magnetic resonance imaging evaluation of adipose tissue and muscle mass in children with growth hormone deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. J Clin Endocrinol Metab 1994; 78: 904-909.
33. Van der Reijden-Lakeman EA. Psychological evaluation of children with short stature after intrauterine growth retardation, before and after two years of growth hormone treatment. Ph.D. Thesis, Erasmus University Rotterdam, 1996.